{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:28:27Z","timestamp":1758047307710,"version":"3.44.0"},"reference-count":24,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.2176\/jns-nmc.2024-0332","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T22:07:53Z","timestamp":1757369273000},"page":"377-382","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Dural Arteriovenous Fistula following Cerebral Venous Sinus Thrombosis Related to COVID-19 Vaccination: A Case Report"],"prefix":"10.2176","volume":"12","author":[{"given":"Naoya","family":"IWABUCHI","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Osaki Citizen Hospital"},{"name":"Preemptive Medicine in the Community of the North Miyagi, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"YOSHIDA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaki Citizen Hospital"},{"name":"Preemptive Medicine in the Community of the North Miyagi, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe","family":"KUMAI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"NISHIJIMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Iwate Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniyasu","family":"NIIZUMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine"},{"name":"Department of Neurosurgical Engineering and Translational Neuroscience, Graduate School of Biomedical Engineering, Tohoku University"},{"name":"Department of Neurosurgical Engineering and Translational Neuroscience, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"ENDO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"doi-asserted-by":"publisher","unstructured":"1) Rizk JG, Gupta A, Sardar P, et al. Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: a review. JAMA Cardiol. 2021;6 (12):1451-60. doi: 10.1001\/jamacardio.2021.3444","key":"1","DOI":"10.1001\/jamacardio.2021.3444"},{"doi-asserted-by":"publisher","unstructured":"2) Schulz JB, Berlit P, Diener HC, et al. COVID-19 vaccine-associated cerebral venous thrombosis in Germany. Ann Neurol. 2021;90 (4):627-39. doi: 10.1002\/ana.26172","key":"2","DOI":"10.1002\/ana.26172"},{"doi-asserted-by":"publisher","unstructured":"3) Hamada Y, Goto K, Inoue T, et al. Histopathological aspects of dural arteriovenous fistulas in the transverse-sigmoid sinus region in nine patients. Neurosurgery. 1997;40 (3):452-6; discussion 456. doi: 10.1097\/00006123-199703000-00005","key":"3","DOI":"10.1097\/00006123-199703000-00005"},{"doi-asserted-by":"publisher","unstructured":"4) Preter M, Tzourio C, Ameri A, et al. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke. 1996;27 (2):243-6. doi: 10.1161\/01.str.27.2.243","key":"4","DOI":"10.1161\/01.STR.27.2.243"},{"doi-asserted-by":"publisher","unstructured":"5) Huang X, Shen H, Fan C, et al. Clinical characteristics and outcome of dural arteriovenous fistulas secondary to cerebral venous sinus thrombosis: a primary or secondary event? BMC Neurol. 2023;23 (1):131. doi: 10.1186\/s12883-023-03141-6","key":"5","DOI":"10.1186\/s12883-023-03141-6"},{"doi-asserted-by":"publisher","unstructured":"6) Kubo M, Kuwayama N. Dural arteriovenous fistulas: dural arteriovenous fistula after cerebral venous sinus thrombosis--what remains still unrevealed? No Kekkannai Chiryo. 2020;5:65-71. doi: 10.20626\/nkc.ra.2019-0001. Japanese.","key":"6","DOI":"10.20626\/nkc.ra.2019-0001"},{"doi-asserted-by":"publisher","unstructured":"7) Suzuki Y, Inatomi Y, Yonehara T. A dural arteriovenous fistula detected during the chronic phase of cerebral venous sinus thrombosis. Rinsho Shinkeigaku. 2016;56 (9):612-6. doi: 10.5692\/clinicalneurol.cn-000899. Japanese.","key":"7","DOI":"10.5692\/clinicalneurol.cn-000899"},{"doi-asserted-by":"publisher","unstructured":"8) Haraguchi K, Matsumoto Y, Kondo R, et al. Percutaneous transluminal sinus angioplasty for transverse sinus-sigmoid sinus stenosis associated with recurrent dural arteriovenous fistula: case report. J Neuroendovascular Ther. 2010;4 (1):33-9. doi: 10.5797\/jnet.4.33. Japanese.","key":"8","DOI":"10.5797\/jnet.4.33"},{"doi-asserted-by":"publisher","unstructured":"9) Satomi J, Nagahiro S. Pathogenesis and natural history of brain arteriovenous malformation and dural arteriovenous fistula. Jpn J Neurosurg. 2013;22 (12):898-903. doi: 10.7887\/jcns.22.898. Japanese.","key":"9","DOI":"10.7887\/jcns.22.898"},{"doi-asserted-by":"publisher","unstructured":"10) Ferro JM, Lopes MG, Rosas MJ, et al. Long-term prognosis of cerebral vein and dural sinus thrombosis. Results of the VENOPORT study. Cerebrovasc Dis. 2002;13 (4):272-8. doi: 10.1159\/000057855","key":"10","DOI":"10.1159\/000057855"},{"unstructured":"11) Barnwell SL, Halbach VV, Dowd CF, et al. Multiple dural arteriovenous fistulas of the cranium and spine. AJNR Am J Neuroradiol. 1991;12 (3):441-5.","key":"11"},{"doi-asserted-by":"publisher","unstructured":"12) Mirza FA, Fraser JF. Multiple dural and pial arteriovenous fistulae in a twenty-four-year-old woman in the setting of superior sagittal sinus thrombosis: case report and review of literature. J Stroke Cerebrovasc Dis. 2016;25 (10):e192-9. doi: 10.1016\/j.jstrokecerebrovasdis.2016.07.037","key":"12","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.037"},{"doi-asserted-by":"publisher","unstructured":"13) Calina D, Docea AO, Petrakis D, et al. Towards effective COVID-19 vaccines: updates, perspectives and challenges (review). Int J Mol Med. 2020;46 (1):3-16. doi: 10.3892\/ijmm.2020.4596","key":"13","DOI":"10.3892\/ijmm.2020.4596"},{"doi-asserted-by":"publisher","unstructured":"14) Oldenburg J, Klamroth R, Langer F, et al. Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH. Hamostaseologie. 2021;41 (3):184-99. doi: 10.1055\/a-1469-7481","key":"14","DOI":"10.1055\/a-1469-7481"},{"doi-asserted-by":"publisher","unstructured":"15) Kawano H, Hashimoto Y, Hirano T. Cerebral vein\/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Rinsho Shinkeigaku. 2021;61 (9):594-601. doi: 10.5692\/clinicalneurol.cn-001646. Japanese.","key":"15","DOI":"10.5692\/clinicalneurol.cn-001646"},{"doi-asserted-by":"publisher","unstructured":"16) Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384 (22):2092-101. doi: 10.1056\/NEJMoa2104840","key":"16","DOI":"10.1056\/NEJMoa2104840"},{"doi-asserted-by":"publisher","unstructured":"17) Aoyama J, Iha H, Ishikawa M, et al. A case of dural arteriovenous fistula following cerebral venous sinus thrombosis associated with the COVID-19 vaccine. J Neuroendovasc Ther. 2023;18 (1):24-8. doi: 10.5797\/jnet.cr.2023-0052","key":"17","DOI":"10.5797\/jnet.cr.2023-0052"},{"doi-asserted-by":"publisher","unstructured":"18) Dias L, Soares-Dos-Reis R, Meira J, et al. Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J Stroke Cerebrovasc Dis. 2021;30 (8):105906. doi: 10.1016\/j.jstrokecerebrovasdis.2021.105906","key":"18","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105906"},{"doi-asserted-by":"publisher","unstructured":"19) Iwakami T, Yamada S, Ogasawara Y, et al. A case of cerebral venous sinus thrombosis following the vaccination with Tozinameran. Rinsho Shinkeigaku. 2022;62 (3):184-9. doi: 10.5692\/clinicalneurol.cn-001656. Japanese.","key":"19","DOI":"10.5692\/clinicalneurol.cn-001656"},{"doi-asserted-by":"publisher","unstructured":"20) Saposnik G, Barinagarrementeria F, Brown RD, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42 (4):1158-92. doi: 10.1161\/STR.0b013e31820a8364","key":"20","DOI":"10.1161\/STR.0b013e31820a8364"},{"doi-asserted-by":"publisher","unstructured":"21) Ferro J. ESO-EAN Guideline on cerebral venous thrombosis. Eur J Neurol. 2017;24:761. doi: 10.1111\/ene.13371","key":"21","DOI":"10.1111\/ene.13371"},{"doi-asserted-by":"publisher","unstructured":"22) Ferro JM, Coutinho JM, Dentali F, et al. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol. 2019;76 (12):1457-65. doi: 10.1001\/jamaneurol.2019.2764","key":"22","DOI":"10.1001\/jamaneurol.2019.2764"},{"doi-asserted-by":"publisher","unstructured":"23) Lee GKH, Chen VH, Tan CH, et al. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis. J Thromb Thrombolysis. 2020;50 (3):724-31. doi: 10.1007\/s11239-020-02106-7","key":"23","DOI":"10.1007\/s11239-020-02106-7"},{"unstructured":"24) Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19). Geneva: World Health Organization; 2023.","key":"24"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/12\/0\/12_2024-0332\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T04:21:01Z","timestamp":1757737261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/12\/0\/12_2024-0332\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":24,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2024-0332","relation":{},"ISSN":["2188-4226"],"issn-type":[{"type":"electronic","value":"2188-4226"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"article-number":"2024-0332"}}